Search results for "Renal Agents"

showing 2 items of 2 documents

V2-receptor–mediated relaxation of human renal arteries in response to desmopressin

1999

The effects of deamino-8-D-arginine vasopressin (desmopressin), a V2 receptor antidiuretic agonist, were studied in isolated rings from branches of renal arteries obtained from 22 patients undergoing nephrectomy. The rings were suspended in organ bath chambers for isometric recording of tension. In precontracted rings with norepinephrine (10(-6) to 3 x 10(-6) mol/L), desmopressin (10(-11) to 3 x 10(-7) mol/L) caused endothelium-dependent relaxation (81%+/-4% reversal of the initial contraction in arteries with endothelium; 20%+/-4% in arteries without endothelium; P < .05). The relaxation to desmopressin in rings with endothelium was reduced significantly by indomethacin (10(-6) mol/L) and …

AdultMaleAgonistReceptors VasopressinVasopressinmedicine.medical_specialtymedicine.drug_classMuscle RelaxationIndomethacinIn Vitro TechniquesRenal AgentsMuscle Smooth VascularRenal ArteryIsometric ContractionArginine vasopressin receptor 2Internal medicineInternal MedicinemedicineHumansCyclooxygenase InhibitorsDeamino Arginine VasopressinEnzyme InhibitorsDesmopressinReceptorAgedVasopressin receptorbusiness.industryAntidiuretic Hormone Receptor AntagonistsMiddle AgedVasodilationNG-Nitroarginine Methyl EsterEndocrinologyCirculatory systemProstaglandinsFemaleNitric Oxide SynthasebusinessAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsmedicine.drugAmerican Journal of Hypertension
researchProduct

Evaluation of antidiuretic hormone before and after long-term treatment with desmopressin in a group of enuretic children

1998

Objective To determine the effect of long-term desmopressin therapy in enuretic patients on the levels of antidiuretic hormone (ADH) during and after the end of therapy. Patients and methods The study comprised 25 outpatients (18 boys and seven girls) aged 8–12 years at the start of therapy and 12–16 years at the end. The morning (08.00 hours) plasma ADH level was determined before treatment (T0) with desmopressin and 2 years after (T1) ending the therapy. Seven of the 25 patients evaluated had monosymptomatic (simple enuresis, SE) and 18 had other symptoms (complex enuresis, CE). Results In the patients with SE, the mean (SD) duration of therapy was 305 (183) days and they were re-evaluate…

Malemedicine.medical_specialtyAdolescentVasopressinsUrologyUrinary incontinenceRenal AgentsGastroenterologyCholinergic AntagonistsEnuresisInternal medicineHumansMedicineDeamino Arginine VasopressinChildOxybutyninDesmopressinMorningbusiness.industryEnuresisLong-Term CareEndocrinologyEl NiñoMandelic AcidsDrug Therapy CombinationFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonistsHormoneAntidiureticmedicine.drugBJU International
researchProduct